Agios Pharmaceuticals (AGIO) Divestments (2020 - 2021)
Agios Pharmaceuticals' (AGIO) quarterly Divestments came in at $1.8 billion in Q1 2021, up 695080.69% YoY from N/an in Q1 2020, and up 395704.4% on a QoQ basis from -$455000.0 in Q4 2020.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) Divestments (2020 - 2021) Analysis & Trends
Agios Pharmaceuticals (AGIO) has 2 years of Divestments data on file, last reported at $1.8 billion in Q1 2021.
- Quarterly Divestments rose 695080.69% year-over-year to $1.8 billion in Q1 2021, while the trailing twelve-month figure through Mar 2022 was -$455000.0 (down 100.03% YoY) and the FY2024 annual result came in at $200.0 million, changed N/A from the prior year.
- Divestments rose to $1.8 billion in Q1 2021, from -$455000.0 in the prior quarter.
- In the past five years, Divestments ranged from a high of $1.8 billion in Q1 2021 to a low of -$455000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Agios Pharmaceuticals | 1.97 Bn | 1.97 Bn | 41.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 1.80 Bn |
| Dec 31, 2020 | -455,000.00 |
| Jun 30, 2020 | -89,000.00 |
| Mar 31, 2020 | -259,000.00 |